Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.049 | 0.9 |
mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |